These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2934199)

  • 1. Defective T-lymphocyte chemotactic factor production in patients with established malignancy.
    Cole D; Van Epps DE; Williams RC
    Clin Immunol Immunopathol; 1986 Feb; 38(2):209-21. PubMed ID: 2934199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-lymphocyte chemotactic activity: nature and production in response to antigen.
    Potter JW; Van Epps DE
    Cell Immunol; 1986 Jan; 97(1):59-66. PubMed ID: 3091270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin.
    Brown SL; Van Epps DE
    J Immunol; 1985 May; 134(5):3384-90. PubMed ID: 3156934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased T lymphocyte migration in patients with malignancy mediated by a suppressor cell population.
    Hesse DG; Cole DJ; Van Epps DE; Williams RC
    J Clin Invest; 1984 Apr; 73(4):1078-85. PubMed ID: 6231310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migration of human helper/inducer T cells in response to supernatants from Con A-stimulated suppressor/cytotoxic T cells.
    Van Epps DE; Durant DA; Potter JW
    J Immunol; 1983 Aug; 131(2):697-700. PubMed ID: 6223091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced human lymphokines that inhibit lymphocyte migration.
    Berman JS; McFadden RG; Cruikshank WW; Center DM; Beer DJ
    J Immunol; 1984 Sep; 133(3):1495-504. PubMed ID: 6379050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a human T lymphocyte chemotactic factor by T cell subpopulations.
    Van Epps DE; Potter JW; Durant DA
    J Immunol; 1983 Jun; 130(6):2727-31. PubMed ID: 6222116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation and purification of lymphocyte chemotactic factor (LCF) and interleukin 2 produced by human peripheral blood mononuclear cells.
    Potter JW; Van Epps DE
    Cell Immunol; 1987 Mar; 105(1):9-22. PubMed ID: 3102082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
    Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
    Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphokine activation of T4+ T lymphocytes and monocytes.
    Cruikshank WW; Berman JS; Theodore AC; Bernardo J; Center DM
    J Immunol; 1987 Jun; 138(11):3817-23. PubMed ID: 3108375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte chemotaxis in inflammation. VI. Lyt phenotype analysis of effector cells responsible for producing murine lymphocyte chemotactic factor.
    Shimokawa Y; Miura K; Hifumi M; Hayashi H
    Immunology; 1983 May; 49(1):95-102. PubMed ID: 6220965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset.
    Berman JS; Cruikshank WW; Center DM; Theodore AC; Beer DJ
    Cell Immunol; 1985 Oct; 95(1):105-12. PubMed ID: 3161625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone suppresses concanavalin A-induced production of chemotactic lymphokines by releasing a soluble factor from splenic T lymphocytes.
    Hirashima M; Sakata K; Tashiro K; Yoshimura T; Hayashi H
    Immunology; 1985 Mar; 54(3):533-40. PubMed ID: 3871733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte chemotaxis in inflammation. VIII. Demonstration of lymphocyte chemotactic lymphokines in PPD-induced delayed hypersensitivity skin reaction site in the guinea-pig.
    Shimokawa Y; Harita S; Mibu Y; Hayashi H
    Immunology; 1984 Feb; 51(2):287-94. PubMed ID: 6693135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral colchicine on T cell subsets, monocytes and concanavalin A-induced suppressor cell function in asthmatic patients.
    Ilfeld DN; Mazar A; Garty M; Fink G; Spitzer S; Pecht M; Netzer L; Trainin N; Kuperman O
    Clin Allergy; 1986 Sep; 16(5):407-16. PubMed ID: 2877755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients.
    Balch CM; Dougherty PA; Cloud GA; Tilden AB
    Surgery; 1984 Jan; 95(1):71-7. PubMed ID: 6229053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte inhibitory and chemotactic factors produced by bursal and thymic lymphocytes.
    Joshi P; Glick B
    Poult Sci; 1990 Feb; 69(2):249-58. PubMed ID: 1691844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular basis for differential lymphokine responses to mitogen stimulation.
    MacSween JM; Rajaraman K; Rajaraman R
    Cell Immunol; 1986 Aug; 101(1):82-92. PubMed ID: 2943417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation.
    Greene WC; Fleisher TA; Waldmann TA
    J Immunol; 1981 Mar; 126(3):1185-91. PubMed ID: 6450803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.